Literature DB >> 22453207

Future trends of mesothelioma mortality in Japan based on a risk function.

Tomoya Myojin1, Kenichi Azuma, Jiro Okumura, Iwao Uchiyama.   

Abstract

Mesothelioma is a malignancy with poor prognosis. It is chiefly caused by asbestos exposure and its symptoms can occur about 30-50 yr after the initial exposure. This study aims to predict the future trends in mesothelioma mortality in Japan using a method that is an alternative to the age-cohort model. Our approach is based on a risk function that links mesothelioma mortality combined with data pertaining to the population, size of the labor force, and quantity of asbestos imports. We projected the number of deaths occurring in individuals aged 50-89 for yr 2003-2050 using risk functions. Our results have indicated that mesothelioma mortality among Japanese people aged 50-89 yr will continue to increase until 2027 and reach a maximum of 66,327 deaths in the years 2003-2050. Our estimate has also suggested that the number of mesothelioma deaths could be significantly reduced if there were adequate compliance with the administrative level guidelines for occupational asbestos exposure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453207     DOI: 10.2486/indhealth.ms1184

Source DB:  PubMed          Journal:  Ind Health        ISSN: 0019-8366            Impact factor:   2.179


  15 in total

1.  Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma.

Authors:  Chi-Fu Jeffrey Yang; Brandon W Yan; Robert Ryan Meyerhoff; Shakir M Saud; Brian C Gulack; Paul J Speicher; Matthew G Hartwig; Thomas A D'Amico; David H Harpole; Mark F Berry
Journal:  Clin Lung Cancer       Date:  2016-03-17       Impact factor: 4.785

2.  Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin.

Authors:  Rui Suzuki; Vishwa Jeet Amatya; Kei Kushitani; Yuichiro Kai; Takahiro Kambara; Yutaro Fujii; Yukio Takeshima
Journal:  Oncol Lett       Date:  2020-04-01       Impact factor: 2.967

Review 3.  Advances in malignant peritoneal mesothelioma.

Authors:  Shoubo Cao; Shi Jin; Jingyan Cao; Jing Shen; Jing Hu; Dehai Che; Bo Pan; Jiawen Zhang; Xiaoxi He; Dian Ding; Feifei Gu; Yan Yu
Journal:  Int J Colorectal Dis       Date:  2014-10-21       Impact factor: 2.571

4.  Malignant mesothelioma: development to therapy.

Authors:  Joyce K Thompson; Catherine M Westbom; Arti Shukla
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

5.  Malignant pleural mesothelioma: an epidemiological perspective.

Authors:  Benjamin M Robinson
Journal:  Ann Cardiothorac Surg       Date:  2012-11

6.  Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis.

Authors:  Daniel G Weber; Swaantje Casjens; Georg Johnen; Oleksandr Bryk; Irina Raiko; Beate Pesch; Jens Kollmeier; Torsten T Bauer; Thomas Brüning
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

7.  Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesothelioma.

Authors:  Akiko Harada; Junji Uchino; Taishi Harada; Noriaki Nakagaki; Junko Hisasue; Masaki Fujita; Koichi Takayama
Journal:  Cancer Sci       Date:  2016-12-01       Impact factor: 6.716

8.  Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey.

Authors:  G L Ceresoli; F Grosso; P A Zucali; M Mencoboni; G Pasello; C Ripa; D Degiovanni; M Simonelli; A Bruzzone; C Dipietrantonj; E Piccolini; G D Beretta; A G Favaretto; L Giordano; A Santoro; M Botta
Journal:  Br J Cancer       Date:  2014-06-10       Impact factor: 7.640

9.  Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020.

Authors:  Gonzalo López-Abente; Montserrat García-Gómez; Alfredo Menéndez-Navarro; Pablo Fernández-Navarro; Rebeca Ramis; Javier García-Pérez; Marta Cervantes; Eva Ferreras; María Jiménez-Muñoz; Roberto Pastor-Barriuso
Journal:  BMC Cancer       Date:  2013-11-06       Impact factor: 4.430

10.  Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections.

Authors:  Carolina Mensi; Sara De Matteis; Barbara Dallari; Luciano Riboldi; Pier Alberto Bertazzi; Dario Consonni
Journal:  Occup Environ Med       Date:  2016-06-16       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.